Patricia Anne Ganz MD

Oncology•Los Angeles, CA

Professor of Medicine, UCLA

Join to View Full Profile

10833 LeConte Ave., A2-125 CHSLos Angeles, CA 90095
Phone+1 310-206-1404
Fax+1 310-206-1404

Summary

I am a medical oncologist and Distinguished Professor of Health Policy & Management AND Medicine at the UCLA Schools of Public Health and Medicine. I am also the Associate Director for Population Science at the UCLA Jonsson Comprehensive Cancer Center. I was elected to the Institute of Medicine (IOM) in 2007, now National Academy of Medicine (NAM). I also served on the National Cancer Institute Board of Scientific Advisors from 2002-2007 and on the American Society of Clinical Oncology (ASCO) Board of Directors from 2003-2006. I received the American Cancer Society Medal of Honor in 2010. In my research I have pioneered the assessment of quality of life in cancer patients, and have focused much of my clinical and research efforts in the areas of breast cancer and its prevention. My major areas of research include cancer survivorship and the late effects of cancer treatment, measurement of patient reported outcomes in clinical treatment trials, and quality of care for cancer patients.

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1976 - 1978
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1973 - 1976
David Geffen School of Medicine at UCLAClass of 1973

Certifications & Licensure

CA State Medical License 1974 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:LA Area Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors:Southern California Castle Connolly, 2012
Fellow (FASCO) American Society of Clinical Oncologists, 2008
Elected Member Institute of Medicine, 2007
Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease Start of enrollment: 1994 Apr 01
Completed
SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial Start of enrollment: 1997 Feb 01
Completed
Letrozole in Preventing Breast Cancer in Postmenopausal Women Start of enrollment: 2002 Feb 01
Completed
Phase 2
Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer Start of enrollment: 2005 Feb 01
Terminated
Phase 2
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
ACTIVE_NOT_RECRUITING
PHASE3
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32 Start of enrollment: 2011 Jul 01
Unknown status
Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors Start of enrollment: 2012 Apr 01
Completed
Phase 2
A Mindfulness Meditation-Based Intervention for Younger Breast Cancer Survivors Start of enrollment: 2011 Apr 01
Completed
Phase 2
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors Start of enrollment: 2015 Aug 03
Completed
Not Applicable
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) Start of enrollment: 2017 Feb 20
Active, not recruiting
Not Applicable
Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors Start of enrollment: 2021 Sep 29
RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial.
Hanna Bandos, Sungjin Kim, N Lynn Henry, Ron D Hays, Vinicius F Calsavara
JNCI Cancer Spectrum. 2025-04-01
Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study.
Mylène Duivon, François Christy, Emilie Thomas, Justine Lequesne, Hélène Castel
Breast Cancer Research. 2025-02-19
2 citations
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment.
Michelle C Janelsins, Kathleen Van Dyk, Sheri J Hartman, Thuy T Koll, Christina K Cramer
Journal of the National Cancer Institute. 2025-02-01

Journal Articles

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study
Susan M Domchek, Wendy K Chung, Patricia A Ganz, Robert L Nussbaum, Journal of the National Cancer Institute
Reproductive and Gynecological Complication Risks Among Thyroid Cancer Survivors
Marcus Monroe, Patricia A Ganz, Journal of Cancer Survivorship
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk
Patricia A Ganz, Amanda E Toland, Susan M Domchek, Tanja Pejovic, Clinical Cancer Research
Aging-Related Disease Risks Among Young Thyroid Cancer Survivors
Patricia A Ganz, Marcus Monroe, John Snyder, Clinical Cancer Research
Functional Mechanisms Underlying Pleiotropic Risk Alleles at the 19p13.1 Breast–Ovarian Cancer Susceptibility Locus
Susan M Domchek, Beth Y Karlan, Katherine L Nathanson, Kenneth Offit, Banu K Arun, Andrew Berchuck, Patricia A Ganz, Douglas A Levine, Nature
Join now to see all

Lectures

Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breas...
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Breast Cancer Survivors Need a Comprehensive Care Plan, Says DoctorFebruary 25th, 2025
Quality-of-Life Outcomes Reported from NRG Oncology Trial Studying Whole-Breast Irradiation vs Accelerated Partial-Breast Irradiation After Breast-Conserving SurgerySeptember 16th, 2024
Breast Cancer Survivors Need a Comprehensive Care Plan, Says DoctorMay 19th, 2023
Join now to see all

Grant Support

Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community SettingsUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029
Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled TrialOHIO STATE UNIVERSITY2023–2028
Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled TrialOHIO STATE UNIVERSITY2023–2028
Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled TrialOHIO STATE UNIVERSITY2023–2028
Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled TrialOHIO STATE UNIVERSITY2023–2028
Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical TrialsCEDARS-SINAI MEDICAL CENTER2023–2025
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical TrialsCEDARS-SINAI MEDICAL CENTER2018–2025
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical TrialsCEDARS-SINAI MEDICAL CENTER2018–2025
Patients And SurvivorsNational Cancer Institute2009–2012
Enhancing Outcomes In Young Breast Cancer Survivors: A Program Of The Ucla-LivestNational Center For Chronic Disease Prev And Health Promo2011
Vitamin D In Breast Cancer: A Cross-Sectional Observational Study In Recently DINational Center For Research Resources2010
The UCLA Familial Cancer Registry And Genetic Evaluation ProgramNational Center For Research Resources2009–2010
Cognitive Functioning After Breast Cancer TreatmentNational Cancer Institute2006–2010
Does Blocking Proinflammatory Cytokines Diminish Cancer-Related Fatigue?National Center For Research Resources2006–2008
The Biopsychosocial Mechanisms Of Fatigue In Breast Cancer SurvivorsNational Center For Research Resources2005
Endocrine /Immune Responses To Stress In Breast Cancer SNational Center For Research Resources2004
Biopsychosocial Mechanisms Of Fatigue In Breast CancNational Center For Research Resources2004
Missed Opportunities For Early Detection &Treatment For Colorectal CancerAgency For Healthcare Research And Quality2000–2002
Breast Cancer--Preparing For SurvivorshipNational Cancer Institute1998–2002
Intraductal Breast Pathology In High Risk WomenNational Center For Research Resources2001
Improving Colorectal Cancer Screening RatesNational Cancer Institute1998–2001
Psychological WELL Being In Long Term Cancer SurvivorsNational Cancer Institute1999
Breast Cancer SurvivorsNational Cancer Institute1994–1998
Breast Cancer Prevention And Control In Older WomenNational Institute On Aging1994–1997